Sign in

CIK 0001411685

  • Non-accelerated filer
  • Smaller reporting company

Vistagen Therapeutics, Inc.

Sign in to watch
Ticker
VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NV
Entity type
Operating
EIN
205093315
Phone
+1 650-577-3600
Business address
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Former names
Excaliber Enterprises, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-07 Prince Joshua S. Chief Operating Officer Grant or award · Incentive Stock Option (right to buy) +18,752 18,752
2026-04-07 Prince Joshua S. Chief Operating Officer Grant or award · Non-Qualified Stock Option (right to buy) +56,248 56,248
2025-12-31 Prince Joshua S. Chief Operating Officer Grant or award +4,386 $0.56 $2K 15,249
2025-06-30 Prince Joshua S. Chief Operating Officer Grant or award +4,882 $1.70 $8K 10,863
2025-06-23 Prince Joshua S. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2024-12-31 Prince Joshua S. Chief Operating Officer Grant or award +3,310 $2.51 $8K 5,981
2024-06-28 Prince Joshua S. Chief Operating Officer Grant or award +2,671 $2.96 $8K 2,671
2024-06-24 Prince Joshua S. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000

Page 1 of 1 · 8 trades